<DOC>
	<DOCNO>NCT00306527</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability immunogenicity ( subset ) follow dose trivalent subunit influenza vaccine produce either mammalian cell embryonated hen egg , healthy adult elderly subject receive either vaccine one year ( 2004 ) study V58P4 .</brief_summary>
	<brief_title>Comparison Safety , Tolerability Immunogenicity Influenza Vaccines Adults Elderly</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . 18 &lt; 61 year age ( first age group ) OR 61 year age old ( second age group ) enrolment V58P4 2 . Mentally competent understand nature , scope consequence study 3 . Able willing give write informed consent prior study entry 4 . Available visit schedule study 5. good health determine : 1 . Medical history relate previous six month , 2 . Physical examination , 3 . Clinical judgment investigator . 1 . Unwilling unable give write informed consent participate study 2 . Currently experience acute infectious disease 3 . Any serious disease , example : 1 . Cancer ( except benign localize skin cancer non metastatic prostate cancer currently treat chemotherapy ) 2 . Autoimmune disease ( include rheumatoid arthritis ) 3 . Advanced arteriosclerotic disease complicate diabetes mellitus 4 . Chronic obstructive pulmonary disease ( COPD ) require oxygen therapy 5 . Acute progressive hepatic disease 6 . Acute progressive renal disease 7 . Congestive heart failure 4 . Surgery plan study period 5 . Bleeding diathesis 6 . History hypersensitivity component study medication chemically related substance , allergy egg egg product 7 . Known suspected impairment/alteration immune function result : 1 . Receipt immunosuppressive therapy ( cortical steroid cancer chemotherapy ) 2 . Receipt immunostimulants 3 . Receipt parenteral immunoglobulin preparation , blood product , and/or plasma derivative within past 3 month full length study 4 . High risk develop immunocompromising disease 8 . History drug alcohol abuse 9 . Laboratory confirm influenza disease past 6 month 10 . Received influenza vaccine within past 6 month 11 . Received another vaccine investigational agent within past 60 day , expect receive another vaccine within 3 week follow study vaccination 12 . Participation another clinical trial within 90 day prior enrollment throughout full length study 13 . Any acute respiratory disease infection require systemic antibiotic antiviral therapy ( chronic antibiotic therapy urinary tract prophylaxis acceptable ) experience fever _ 38Â°C within past 5 day 14 . Pregnant/ breast feed woman woman refuse use reliable contraceptive method first three week vaccination 15 . Any condition , opinion investigator , might interfere evaluation study objective .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Influenza</keyword>
	<keyword>adult/elderly</keyword>
	<keyword>flu cell culture</keyword>
	<keyword>vaccine</keyword>
</DOC>